ATE180969T1 - Pharmazeutische zusammensetzungen enthaltend urodeoxycholicsäure - Google Patents
Pharmazeutische zusammensetzungen enthaltend urodeoxycholicsäureInfo
- Publication number
- ATE180969T1 ATE180969T1 AT93118886T AT93118886T ATE180969T1 AT E180969 T1 ATE180969 T1 AT E180969T1 AT 93118886 T AT93118886 T AT 93118886T AT 93118886 T AT93118886 T AT 93118886T AT E180969 T1 ATE180969 T1 AT E180969T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions containing
- pharmaceutical compositions
- acid
- urodeoxycholic
- urodeoxycholic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI922721A IT1255968B (it) | 1992-11-27 | 1992-11-27 | Composizioni farmaceutiche contenenti acido ursodesossicolico |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE180969T1 true ATE180969T1 (de) | 1999-06-15 |
Family
ID=11364369
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93118886T ATE180969T1 (de) | 1992-11-27 | 1993-11-24 | Pharmazeutische zusammensetzungen enthaltend urodeoxycholicsäure |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0599282B1 (de) |
AT (1) | ATE180969T1 (de) |
DE (1) | DE69325236T2 (de) |
ES (1) | ES2134237T3 (de) |
IT (1) | IT1255968B (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7772220B2 (en) | 2004-10-15 | 2010-08-10 | Seo Hong Yoo | Methods and compositions for reducing toxicity of a pharmaceutical compound |
ITMI20012572A1 (it) * | 2001-12-06 | 2003-06-06 | Istituto Biochimico Italiano | Microgranuli di acido ursodesossicolico |
US7145125B2 (en) | 2003-06-23 | 2006-12-05 | Advanced Optical Technologies, Llc | Integrating chamber cone light using LED sources |
BRPI0514725A (pt) | 2004-08-30 | 2008-06-24 | Seo Hong Yoo | efeito neuroprotetor de udca solubilizado no modelo isquêmico focal |
EP1809330B1 (de) | 2004-10-15 | 2011-04-27 | Seo Hong Yoo | Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin |
CA2588168A1 (en) * | 2004-11-24 | 2006-06-01 | Seo Hong Yoo | Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof |
CA2684586A1 (en) * | 2007-04-19 | 2008-10-30 | Disphar International B.V. | High dose composition of ursodeoxycholic acid |
MX2009001925A (es) * | 2009-02-20 | 2010-08-20 | Senosiain S A De C V Lab | Composicion farmaceutica oral para uso en enfermedades respiratorias. |
ITTO20111064A1 (it) * | 2011-11-18 | 2013-05-19 | Abc Farmaceutici S P A | Compresse a rilascio protratto, comprendenti acido ursodesossicolico |
US20220304937A1 (en) * | 2015-09-16 | 2022-09-29 | Laboratoires C.T.R.S. | Pediatric formulation |
CN107095858B (zh) * | 2017-06-27 | 2020-04-10 | 石家庄学院 | 一种熊去氧胆酸胶囊及其制备方法 |
CN107496928B (zh) * | 2017-09-11 | 2020-07-14 | 石家庄学院 | 一种熊去氧胆酸干混悬剂及其制备方法 |
EP3989943A1 (de) * | 2019-06-28 | 2022-05-04 | Tilman | Zusammensetzung mit mindestens einem triterpen und/oder mindestens einem triterpenoid und/oder mindestens einer der glykosylierten formen davon |
CN110478304B (zh) * | 2019-08-20 | 2022-07-05 | 广州市金熊大健康科技有限公司 | 一种含有熊胆微胶囊的牙膏 |
WO2024023669A1 (en) * | 2022-07-25 | 2024-02-01 | Shilpa Medicare Limited | Pharmaceutical compositions of nor-udca |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0747539B2 (ja) * | 1986-10-22 | 1995-05-24 | 東京田辺製薬株式会社 | 胆汁酸固形製剤 |
GB8722306D0 (en) * | 1987-09-22 | 1987-10-28 | Aps Research Ltd | Sustained-release formulation |
IT1245891B (it) * | 1991-04-12 | 1994-10-25 | Alfa Wassermann Spa | Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali. |
US5260074A (en) * | 1992-06-22 | 1993-11-09 | Digestive Care Inc. | Compositions of digestive enzymes and salts of bile acids and process for preparation thereof |
-
1992
- 1992-11-27 IT ITMI922721A patent/IT1255968B/it active IP Right Grant
-
1993
- 1993-11-24 EP EP93118886A patent/EP0599282B1/de not_active Expired - Lifetime
- 1993-11-24 DE DE69325236T patent/DE69325236T2/de not_active Expired - Fee Related
- 1993-11-24 AT AT93118886T patent/ATE180969T1/de not_active IP Right Cessation
- 1993-11-24 ES ES93118886T patent/ES2134237T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0599282A1 (de) | 1994-06-01 |
ES2134237T3 (es) | 1999-10-01 |
IT1255968B (it) | 1995-11-17 |
ITMI922721A1 (it) | 1994-05-27 |
DE69325236T2 (de) | 2000-01-27 |
ITMI922721A0 (it) | 1992-11-27 |
EP0599282B1 (de) | 1999-06-09 |
DE69325236D1 (de) | 1999-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE180969T1 (de) | Pharmazeutische zusammensetzungen enthaltend urodeoxycholicsäure | |
ATE108657T1 (de) | Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus. | |
ES2071621T3 (es) | Enantiomero dextrogiro del alfa-(tetrahidro-4,5,6,7-tieno-(3,2-c)-piridil-5)(cloro-2-fenil) acetato de metilo, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen. | |
ES479474A1 (es) | Procedimiento para la obtencion de una composicion a base dederivados de la piridina de accion cerebral. | |
MX9204861A (es) | Analogos de polipeptidos que tienen actividad liberadora de la hormona de crecimiento. | |
EP0668073A3 (de) | Polyester Matrix für eine pharmazeutische Zusammensetzung mit verzögerter Freigabe. | |
DK98088D0 (da) | Farmaceutisk formulering med forsinket frigivelse af den aktive bestanddel | |
DE3862337D1 (de) | Pharmazeutische zubereitungen, die ester oder amide als wirkstoffe enthalten. | |
FI870457A0 (fi) | Farmaceutiska preparatformer foer stabilisering av interferon- . | |
BR9401199A (pt) | Preparados de medicamentos, processo para a preparação de um preparado de medicamento, processo para a preparação de uma formulação de medicamento. | |
NO172580C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte n-(1-alkyl-3-hydroksy-4-piperidinyl)benzamider | |
ATE79538T1 (de) | Dispergierbare zubereitung. | |
ATE94765T1 (de) | Pharmazeutische praeparate zur verbesserten resorption antibakterieller verbindungen. | |
DE68926115D1 (de) | Verfahren zur behandlung von akne | |
HUT51105A (en) | Pesticide comprising substituted acrylic acid ester derivatives as active ingredient and process for producing the active ingredients | |
BG88028A (bg) | Амиди на циклометилен-1,2-дикарбоксилни киселини с терапевтична активност,методи за получаването им и фармацевтични състави, които ги съдържат | |
IT1204400B (it) | Composizioni farmaceutiche contenente una calcitonina | |
UA74388C2 (uk) | Фармацевтичні композиції тизоксаніду і нітазоксаніду | |
ZA91115B (en) | Topical compositions | |
NO172491C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater | |
EP0351876A3 (de) | Zusammensetzung zur Steigerung der Impfungswirkung | |
IT1140789B (it) | Esteri sostituiti dell'acido ciclopropancarbossilico e composizioni insetticide che contengono i medesimi come ingrediente attivo | |
EP0335446A3 (de) | Mittel zur Behandlung von Neoplasmen | |
PT88320A (pt) | Process for the preparation of thionoalkawephosphonates of o (6-methyl-2-alkyl-pyrimidine-4-ilo) and of o-alkyl with insecticide acaricide and/or nematodocide effect | |
SE8700829L (sv) | Farmaceutisk komposition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |